Patent · US Active

Hydroxyl purine compounds and applications thereof

US10098885B2 · kind B2 · utility

0Cited by
5References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 22, 2015
Grant dateOct 16, 2018
Priority date
Expiry dateSep 22, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D473/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Hydroxyl purine compounds represented by formula (I), tautomers or pharmaceutically acceptable salts thereof, and applications thereof as PDE2 or TNF-α inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.